A very recent review from Zuazo et al. [67] showed that the presence of specific CD4 T-cell memory subsets in peripheral blood before the initiation of treatments is a strong predictor of responses in non-small-cell lung cancer patients. This evidence concerns the gene CD4 and non-small cell lung carcinoma.